Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study for the Assessment of the Long-term Safety and Efficacy of Cx401 in Patients Taking Part in the FATT-1 Trial

NCT01020825 is registered in ClinicalTrials.gov with Tigenix S.A.U. as lead sponsor.

NCT NCT01020825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study for the Assessment of the Long-term Safety and Efficacy of Cx401 in Patients Taking Part in the FATT-1 Trial
Lead sponsor
Tigenix S.A.U.
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
May 31, 2010
Enrollment
148 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

complex perianal fistula